novo nordisk oral semaglutide Company of the year 2023: – Riding the wave Novo says oral semaglutide works

You begin treatment during a shortage period and receive compounded semaglutide in pre-filled syringes

At week 68, mean weight loss with CagriSema was approximately 20.4% under the treatment-policy estimand (up to ~22.7% under the trial-product estimand) versus roughly 14.9% with semaglutide, 11.5% with cagrilintide, and 3.0% with placebo

Available at: [accessed March 2026]. Pediatric obesity research update: Once-weekly semaglutide in adolescents with obesity (STEP TEENS)

Individuals with a personal or family history of medullary thyroid carcinoma or MEN2 should discuss risks with their clinician before enrolment

In addition, GLP-1 drugs work on the brain to suppress appetite, says Dr

2 Less than 1% of patients in an efficacy and safety trial reported a skin adverse event